Albireo Pharma (FRA:BDQM) EBITDA Margin % : -357.47% (As of Sep. 2022)

Albireo Pharma EBITDA Margin % Chart

Albireo Pharma Annual Data
	Trend	Sep12	Sep13	Sep14	Sep15	Sep16	Dec17	Dec18	Dec19	Dec20	Dec21
EBITDA Margin %		Get a 7-Day Free Trial					-2,073,800.00	-323.47	-594.61	-1,156.49	-48.85

Albireo Pharma Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBITDA Margin %	Get a 7-Day Free Trial															1,755.07	-35.01	-577.38	-452.34	-357.47

Competitive Comparison of Albireo Pharma's EBITDA Margin %

For the Biotechnology subindustry, Albireo Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Albireo Pharma's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albireo Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Albireo Pharma's EBITDA Margin % falls into.

Albireo Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Albireo Pharma's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Albireo Pharma's EBITDA Margin % for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albireo Pharma  (FRA:BDQM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Albireo Pharma EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Albireo Pharma's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Albireo Pharma (FRA:BDQM) Business Description